KRYS

Krystal Biotech

• Benzinga·8h ago

  Here’s How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years

• Simply Wall St·2d ago

  Krystal Biotech (KRYS) Rallies On Pipeline Hopes But Is The Valuation Already Priced In

• NASDAQ·4d ago

  Noteworthy Friday Option Activity: PZZA, CRK, KRYS

• TipRanks·08/16 13:51

  Krystal Biotech initiated with an Outperform at RBC Capital

• TipRanks·08/16 13:09

  Micron upgraded, Cisco downgraded: Wall Street’s top analyst calls

• Simply Wall St·08/16 01:22

  Should Surging Vyjuvek-Driven Earnings Reshape How Krystal Biotech (KRYS) Investors View Its Risk Profile?

• TipRanks·08/15 02:07

  High-Profile Insider Trade Shakes Up Krystal Biotech

• Seeking Alpha·08/14 14:27

  Krystal Bio granted bullish view at RBC after blockbuster projections

• Dow Jones·08/14 14:25

  Krystal Biotech Price Target Announced at $400.00/Share by RBC Capital

• Dow Jones·08/14 14:25

  Krystal Biotech Initiated at Outperform by RBC Capital

• Benzinga·08/14 14:15

  RBC Capital Initiates Coverage On Krystal Biotech with Outperform Rating, Announces Price Target of $400

• TipRanks·08/14 12:38

  Krystal Biotech (KRYS) Has a New Rating from RBC Capital

• Simply Wall St·08/13 00:37

  Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus

• TipRanks·08/12 14:20

  Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS) and Immunic (IMUX)

• Dow Jones·08/10 20:34

  Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers